Parallax Volatility Advisers’s Medifast MED Stock Holding History

Parallax Volatility Advisers’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-33,000	Closed	-$2.47M	–	2372
2023 Q3	$2.47M	Buy	+33,000	New	+$2.93M	0.01%	1017
2019 Q3	–	Sell	-10,000	Closed	-$1.28M	–	3012
2019 Q2	$1.28M	Buy	+10,000	New	+$1.39M	﹤0.01%	1190
2017 Q2	–	Sell	-600	Closed	-$27K	–	3268
2017 Q1	$27K	Buy	+600	New	+$25.8K	﹤0.01%	2861
2015 Q2	–	Sell	-3,500	Closed	-$105K	–	4422
2015 Q1	$105K	Sell	3,500 -5,400	-61%	-$171K	﹤0.01%	2498
2014 Q4	$298K	Buy	8,900 +1,200	+16%	+$37.4K	﹤0.01%	2487
2014 Q3	$253K	Buy	7,700 +6,600	+600%	+$203K	﹤0.01%	2316
2014 Q2	$33K	Sell	1,100 -3,700	-77%	-$115K	﹤0.01%	3209
2014 Q1	$139K	Buy	4,800 +2,400	+100%	+$64.3K	﹤0.01%	1677
2013 Q4	$63K	Buy	2,400 +400	+20%	+$10.2K	﹤0.01%	2106
2013 Q3	$53K	Buy	2,000 +1,500	+300%	+$40.1K	﹤0.01%	1784
2013 Q2	$13K	Buy	+500	New	+$13.1K	﹤0.01%	2147

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parallax Volatility Advisers's MED Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Medifast (MED) in Q4 2018, closing a stake of 25 shares — an estimated $6K sold.

Parallax Volatility Advisers first reported a position in MED in Q3 2013 and held it in 8 quarters. The position peaked at $111K in Q4 2017. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

Parallax Volatility Advisers reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 25 Medifast shares in Q4 2018, an estimated $6K.
Parallax Volatility Advisers first reported a position in Medifast in Q3 2013 and held it in 8 quarters.
Parallax Volatility Advisers's Medifast position peaked at $111K in Q4 2017.
247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.